Astrazeneca Copd Treatment Completes Phase Iii Studies

AstraZeneca's potential COPD treatment improved lung function in patients during two Phase III clinical trials.        

Sections:  u.s.   
Topics:  Delaware   New Castle County   Wilmington   
RELATED ARTICLES
BING NEWS:
  • Verona touts 'exceptionally strong' launch of blockbuster hopeful COPD treatment Ohtuvayre
    But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.
    01/7/2025 - 4:27 am | View Link
  • Sarepta completes subject dosing in Phase III LGMD2E/R4 therapy trial
    Sarepta Therapeutics has completed enrolment and dosing in the global Phase III EMERGENE trial of its investigational gene therapy, SRP-9003 (bidridistrogene xeboparvovec), aimed at treating ...
    12/19/2024 - 9:59 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News